Dr. Schreiber is the Alumni Endowed Professor of Pathology & Immunology at Washington University School of Medicine and Leader of the Tumor Immunology Program of the Washington University Siteman Cancer Center. He received his undergraduate and graduate training in Biochemistry and Immunology from the State University of New York at Buffalo, and his postdoctoral training in molecular immunology at the Scripps Research Institute in La Jolla, California.
UK
London Research Institute
Dr. I an Kerr has had a long and very distinguished career studying the mechanism of action of the interferons. Obtaining his Ph.D. in 1963, he did postdoctoral work at Stanford and MIT, and was a group leader at the MRC National Institute of Medical Research for many years before moving to Lincoln’s Inn Fields in 1980.
Dr. Kerr has made numerous ground-breaking contributions to our understanding of how interferons alter cellular behavior. Dr. Kerr was made a Fellow of the Royal Society in 1985. Dr. Kerr retired in 2005 as a senior group leader at Lincoln’s Inn Fields, London Research Institute.
USA
Johns Hopkins School of Medicine
Dr. Pitha-Rowe has been interested in the effects viral infection on the expression of cellular genes and in the novel approaches to modulation of the antiviral and anti-inflammatory responses. She received her Ph.D. from the Academy of Sciences, Prague, Czech Republic and did postgraduate training in the Institute of Organic Chemistry and Biochemistry, Prague and at the Johns Hopkins University School of Medicine.
Aaron M Ring
Assistant Professor of Immunobiology, Yale University School of Medicine
New Haven, United States
Elia Tait Wojno
Assistant Professor
Department of Immunology, University of Washington
Seattle, USA
Zhenyu Zhong
Assistant Professor
Department of Immunology,
University of Texas Southwestern Medical Center
Dallas, USA
Here are some of the emerging scientists in the field of interferon and cytokine research:
Juan Luis Mendoza
|
|
|
|
|
| Sarah Doyle
|
|
|
|
| Juan Fuxman Bass
|
|
|
|
|
| Yuxin Wang
|
|
|
|
| Ryan A. Langlois
|
|
|
Cristina Bergmaschi
Dr. Bergamaschi received her Ph.D. in Molecular Medicine specializing in Immunology from the University of Milan, Italy in 2008. |
|
|
|
|
Ricardo Rajsbaum
Dr. Rajsbaum performed his PhD in the laboratory of Anne O’Garra at the MRC-NIMR, London in 2009, and completed his postdoctoral training at Mount Sinai School of Medicine, New York, with Dr Adolfo Garcia-Sastre. |
|
|
|
Greg Sonnenberg
|
|
|
|
|
Munir Akkaya
Dr. Munir Akkaya received his MD degree from Hacettepe University, Turkey in 2007 and D.Phil (PhD) degree from the University of Oxford in 2012. |
|
|
|
Ari Molofsky
Ari Molofsky received a BS in Molecular Biology from the University of Texas in 1999 and completed his MD/PhD at the University of Michigan in 2007. |
|
|
Kiyoshi Hirahara
Dr. Hirahara graduated from Niigata University school of Medicine in 2001. |
|
|
Christian Kanstrup
Christian Kanstrup Holm received his PhD in December 2009 from Faculty of Health Sciences at Aarhus University. |
|
|
Tatsuma Ban
Dr. Ban received his Ph.D. in 2012 from the University of Tokyo, Japan under the mentorship of Prof. Tadatsugu Taniguchi. |
|
|
USA
Dr. Rathinam received his Doctorate of Veterinary Medicine from Madras Veterinary College, India and PhD from Michigan State University in 2009.
Dr. Sonnenberg completed his doctoral research training at the University of Pennsylvania, Perelman School of Medicine in 2011, focusing on mucosal immunology.
